The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Personalized oncology: Recent advances and future challenges
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rational, biologically based treatment of EGFR-mutant non-small-cell lung cancer
Pao, W., & Chmielecki, J. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2947 · Cited by 1,083 · cited 3×
“EGFR (noted in <10% of adenocarcinomas) have specific clinical presentations and targeted treatments [20].”
BackgroundTian, Q., Price, N. D., & Hood, L. (2012) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2011.02498.x · Cited by 224 · cited 2×
“For example, a new paradigm (P4) in systems medicine has evolved: “predictive, preventive, personalized and participatory (P4)” medicine which includes societal challenges, in addition to all the elements of oncology medicine [11].”
Background
Cited by
Das, V., Kalita, J., & Pal, M. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.12.064 · Cited by 275
Biomarkers for personalized oncology: recent advances and future challenges
Kalia, M. (2015) · Metabolism · doi:10.1016/j.metabol.2014.10.027 · Cited by 265
Self-citationIron oxide-loaded nanotheranostics: major obstacles to in vivo studies and clinical translation
Schleich, N., Danhier, F., & Préat, V. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.11.024 · Cited by 124
“Personalized medicine as an evidence-based individualized medicine able to deliver the right treatment to the right patient at the right time, could both improve disease outcomes and reduce overall healthcare costs [133].”
BackgroundPrecision Treatment and Precision Prevention: Integrating “Below and Above the Skin”
Gillman, M. W., & Hammond, R. A. (2016) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2015.2786 · Cited by 76
Integrated diagnostics: the future of laboratory medicine?
Lippi, G., & Plebani, M. (2020) · Biochemia medica · doi:10.11613/bm.2020.010501 · Cited by 64
Metadata
- Authors
- Kalia, M.
- Venue
- Metabolism
- Publisher
- Elsevier BV
- Published
- 2013-01
- Volume
- 62
- Pages
- S11-S14
- ISSN
- 0026-0495 (ISSN-L)
- OpenAlex
- W2034726139
- Cited by
- 186
- References
- 2
- FWCI
- 6.03
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.